세계의 게놈 선택 플랫폼 시장 보고서(2025년)

A genomic selection platform is a technology-driven system that leverages genome-wide genetic information to predict the performance or breeding potential of plants, animals, or microorganisms. It accelerates selective breeding by identifying individuals with the most desirable traits early, minimizing the need for prolonged traditional evaluation cycles. The platform integrates high-throughput genotyping, statistical modeling, and predictive algorithms to enable efficient, informed selection decisions.

The primary components of a genomic selection platform are software, hardware, and services. Software includes specialized computational tools and applications designed to process and analyze large-scale genomic data to support breeding programs. It can be implemented through on-premises or cloud-based systems and finds applications in plant breeding, animal breeding, human genomics, and more. Key end-users comprise research institutions, biotechnology firms, agricultural organizations, and other stakeholders.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The genomic selection platform market research report is one of a series of new reports from The Business Research Company that provides genomic selection platform market statistics, including the genomic selection platform industry global market size, regional shares, competitors with the genomic selection platform market share, detailed genomic selection platform market segments, market trends, and opportunities, and any further data you may need to thrive in the genomic selection platform industry. This genomic selection platform market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The genomic selection platform market size has grown rapidly in recent years. It will grow from $1.94 billion in 2024 to $2.27 billion in 2025 at a compound annual growth rate (CAGR) of 17.3%. The growth in the historic period can be linked to the expansion of agricultural biotechnology, increasing use of quantitative genetics in breeding programs, heightened focus on disease resistance in crops and livestock, growth of collaborative research initiatives, and rising challenges from disease pressures and climate variability.

The genomic selection platform market size is expected to see rapid growth in the next few years. It will grow to $4.25 billion in 2029 at a compound annual growth rate (CAGR) of 16.9%. The growth in the forecast period can be linked to rising global food demand, expansion of precision agriculture, increased emphasis on sustainable breeding practices, growth in livestock genomics, and the rise of contract breeding and genomic services. Key trends during the forecast period include advancements in next-generation sequencing (NGS), integration with digital agriculture tools, adoption of AI and machine learning, implementation of cloud-based genomic data platforms, and integration of multi-omics data.

The growing adoption of personalized medicine is expected to drive the expansion of the genomic selection platform market. Personalized medicine tailors treatment and prevention strategies based on an individual's unique genetic makeup, lifestyle, and environment. This trend is largely fueled by advancements in genomics, which allow for the precise identification of genetic variations and the development of customized treatments. Genomic selection platforms play a critical role in supporting personalized medicine by offering precise genomic insights, enabling treatments that are specifically designed for each patient. These platforms minimize trial-and-error in therapy selection by predicting how patients will respond to different interventions, ultimately improving treatment effectiveness and patient outcomes. For example, in February 2024, the Personalized Medicine Coalition reported that the U.S. Food and Drug Administration approved 26 new personalized medicines in 2023, up from 12 in 2022. This increase highlights the growing role of personalized medicine, which is fueling the demand for genomic selection platforms.

The rise in crop yields is expected to drive growth in the genomic selection platform market. Crop yield, which refers to the amount of agricultural output produced per unit of land, is increasing due to advancements in agricultural biotechnology that improve plant genetics and resilience. Genomic selection platforms play a key role in enhancing crop yields by enabling the precise selection of high-performing plant varieties, making them essential for modern agriculture and breeding programs. These platforms reduce the time and cost associated with traditional breeding methods by offering accurate genetic predictions, which in turn boosts farm productivity and food security. For instance, in February 2024, the Department for Environment, Food and Rural Affairs reported that the UK's cereal production reached 24.3 million tonnes in 2022, an 8% increase compared to 2021. This rise in crop yields further underscores the growing importance of genomic selection platforms in agriculture.

Leading companies in the genomic selection platform market are increasingly focusing on developing innovative solutions such as targeted sequencing platforms to improve trait prediction and accelerate breeding programs. Targeted sequencing platforms are genomic technologies that focus on sequencing specific regions of the genome, rather than sequencing the entire genome. For example, in October 2024, Element Biosciences launched Trinity, a breakthrough targeted sequencing platform designed to streamline exome capture by integrating traditionally complex steps into its AVITI System. The platform eliminates the need for specialized equipment, reduces manual work by up to five hours, and offers a one-hour hybridization option for same-day results, making it highly suitable for time-sensitive studies. Trinity can be expanded to support custom panels for various applications, including oncology, respiratory diseases, and minimal residual disease (MRD), offering faster, more cost-effective, and accessible sequencing. This marks a significant advancement in exome capture technology.

Major players in the genomic selection platform market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., GE Healthcare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., MGI Tech Co. Ltd., Azenta Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Ultima Genomics Inc., Element Biosciences Inc., DNAnexus Inc., Deep Genomics Inc., Epigene Labs Inc., Quotient Therapeutics Inc., Evogene Ltd., Nebula Genomics Inc., Verinomics Inc., InEdita Bio Inc., GenEmbryomics Inc., and Enigma Genomics Inc.

North America was the largest region in the genomic selection platform market in 2024. The regions covered in genomic selection platform report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the genomic selection platform market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The genomic selection platform market consists of revenues earned by entities by providing services such as genotyping, phenotyping, data analysis and interpretation, predictive modeling, breeding program management, and consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The genomic selection platform market also includes sales of genotyping platforms, sequencing platforms, bioinformatics software, data analysis tools, marker-assisted selection tools, DNA extraction kits, and high-throughput genotyping assays. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Genomic Selection Platform Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on genomic selection platform market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for genomic selection platform ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The genomic selection platform market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Component: Software; Hardware; Services
• 2) By Deployment Mode: On-Premises; Cloud-Based
• 3) By Application: Plant Breeding; Animal Breeding; Human Genomics; Other Applications
• 4) By End-User: Research Institutes; Biotechnology Companies; Agricultural Organizations; Other End Users
• Subsegments:
• 1) By Software: Genomic Data Management Software; Bioinformatics And Statistical Analysis Tools; DNA Or RNA Sequencing Data Processing Software; Genomic Prediction And Modeling Software; Cloud-Based Genomic Platforms; Workflow Automation And Integration Tools
• 2) By Hardware: Next-Generation Sequencing (NGS) Systems; Polymerase Chain Reaction (PCR) Instruments; Microarray Analyzers; High-Performance Computing (HPC) Systems; Data Storage Servers; Laboratory Automation And Robotics
• 3) By Services: Sequencing And Genotyping Services; Data Analysis And Interpretation Services; Cloud Hosting & Data Storage Services; Custom Bioinformatics Solutions; Training And Technical Support Services; Consulting And Implementation Services
• Companies Mentioned: F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; GE Healthcare Technologies Inc.; Eurofins Scientific SE; Agilent Technologies Inc.; Illumina Inc.; Beckman Coulter Inc.; Bio-Rad Laboratories Inc.; QIAGEN N.V.; MGI Tech Co. Ltd.; Azenta Inc.; 10x Genomics Inc.; Oxford Nanopore Technologies plc; Ultima Genomics Inc.; Element Biosciences Inc.; DNAnexus Inc.; Deep Genomics Inc.; Epigene Labs Inc.; Quotient Therapeutics Inc.; Evogene Ltd.; Nebula Genomics Inc.; Verinomics Inc.; InEdita Bio Inc.; GenEmbryomics Inc.; Enigma Genomics Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Genomic Selection Platform Market Characteristics

3. Genomic Selection Platform Market Trends And Strategies

4. Genomic Selection Platform Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Genomic Selection Platform Growth Analysis And Strategic Analysis Framework

• 5.1. Global Genomic Selection Platform PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Genomic Selection Platform Market Growth Rate Analysis
• 5.4. Global Genomic Selection Platform Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Genomic Selection Platform Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Genomic Selection Platform Total Addressable Market (TAM)

6. Genomic Selection Platform Market Segmentation

• 6.1. Global Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Software
• Hardware
• Services
• 6.2. Global Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• On-Premises
• Cloud-Based
• 6.3. Global Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Plant Breeding
• Animal Breeding
• Human Genomics
• Other Applications
• 6.4. Global Genomic Selection Platform Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Research Institutes
• Biotechnology Companies
• Agricultural Organizations
• Other End Users
• 6.5. Global Genomic Selection Platform Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genomic Data Management Software
• Bioinformatics And Statistical Analysis Tools
• DNA Or RNA Sequencing Data Processing Software
• Genomic Prediction And Modeling Software
• Cloud-Based Genomic Platforms
• Workflow Automation And Integration Tools
• 6.6. Global Genomic Selection Platform Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Next-Generation Sequencing (NGS) Systems
• Polymerase Chain Reaction (PCR) Instruments
• Microarray Analyzers
• High-Performance Computing (HPC) Systems
• Data Storage Servers
• Laboratory Automation And Robotics
• 6.7. Global Genomic Selection Platform Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sequencing And Genotyping Services
• Data Analysis And Interpretation Services
• Cloud Hosting And Data Storage Services
• Custom Bioinformatics Solutions
• Training And Technical Support Services
• Consulting And Implementation Services

7. Genomic Selection Platform Market Regional And Country Analysis

• 7.1. Global Genomic Selection Platform Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Genomic Selection Platform Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Genomic Selection Platform Market

• 8.1. Asia-Pacific Genomic Selection Platform Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Genomic Selection Platform Market

• 9.1. China Genomic Selection Platform Market Overview
• 9.2. China Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Genomic Selection Platform Market

• 10.1. India Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Genomic Selection Platform Market

• 11.1. Japan Genomic Selection Platform Market Overview
• 11.2. Japan Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Genomic Selection Platform Market

• 12.1. Australia Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Genomic Selection Platform Market

• 13.1. Indonesia Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Genomic Selection Platform Market

• 14.1. South Korea Genomic Selection Platform Market Overview
• 14.2. South Korea Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Genomic Selection Platform Market

• 15.1. Western Europe Genomic Selection Platform Market Overview
• 15.2. Western Europe Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Genomic Selection Platform Market

• 16.1. UK Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Genomic Selection Platform Market

• 17.1. Germany Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Genomic Selection Platform Market

• 18.1. France Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Genomic Selection Platform Market

• 19.1. Italy Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Genomic Selection Platform Market

• 20.1. Spain Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Genomic Selection Platform Market

• 21.1. Eastern Europe Genomic Selection Platform Market Overview
• 21.2. Eastern Europe Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Genomic Selection Platform Market

• 22.1. Russia Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Genomic Selection Platform Market

• 23.1. North America Genomic Selection Platform Market Overview
• 23.2. North America Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Genomic Selection Platform Market

• 24.1. USA Genomic Selection Platform Market Overview
• 24.2. USA Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Genomic Selection Platform Market

• 25.1. Canada Genomic Selection Platform Market Overview
• 25.2. Canada Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Genomic Selection Platform Market

• 26.1. South America Genomic Selection Platform Market Overview
• 26.2. South America Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Genomic Selection Platform Market

• 27.1. Brazil Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Genomic Selection Platform Market

• 28.1. Middle East Genomic Selection Platform Market Overview
• 28.2. Middle East Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Genomic Selection Platform Market

• 29.1. Africa Genomic Selection Platform Market Overview
• 29.2. Africa Genomic Selection Platform Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Genomic Selection Platform Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Genomic Selection Platform Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Genomic Selection Platform Market Competitive Landscape And Company Profiles

• 30.1. Genomic Selection Platform Market Competitive Landscape
• 30.2. Genomic Selection Platform Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Genomic Selection Platform Market Other Major And Innovative Companies

• 31.1. Illumina Inc.
• 31.2. Beckman Coulter Inc.
• 31.3. Bio-Rad Laboratories Inc.
• 31.4. QIAGEN N.V.
• 31.5. MGI Tech Co. Ltd.
• 31.6. Azenta Inc.
• 31.7. 10x Genomics Inc.
• 31.8. Oxford Nanopore Technologies plc
• 31.9. Ultima Genomics Inc.
• 31.10. Element Biosciences Inc.
• 31.11. DNAnexus Inc.
• 31.12. Deep Genomics Inc.
• 31.13. Epigene Labs Inc.
• 31.14. Quotient Therapeutics Inc.
• 31.15. Evogene Ltd.

32. Global Genomic Selection Platform Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Genomic Selection Platform Market

34. Recent Developments In The Genomic Selection Platform Market

35. Genomic Selection Platform Market High Potential Countries, Segments and Strategies

• 35.1 Genomic Selection Platform Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Genomic Selection Platform Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Genomic Selection Platform Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer